共 714 条
- [1] aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, Mathew SJ, CG(2010)Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression Biol Psychiatry 67 139-145
- [2] Abdallah G(2018)The neurobiology of depression, ketamine and rapid-acting antidepressants: is it glutamate inhibition or activation? Pharmacol Ther 190 148-158
- [3] Sanacora RS(2021)Therapeutic potential of curcumin in reversing the depression and associated pseudodementia via modulating stress hormone, hippocampal neurotransmitters, and BDNF levels in rats Neurochem Res 46 3273-3285
- [4] Duman JH(2019)(R)-Ketamine induces a greater increase in prefrontal 5-HT release than (S)-ketamine and ketamine metabolites via an AMPA receptor-independent mechanism Int J Neuropsychopharmacol 22 665-674
- [5] Krystal A(2017)Adult hippocampal neurogenesis and cognitive flexibility—linking memory and mood Nat Rev Neurosci 18 335-346
- [6] Afzal Z(2007)Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia Eur J Clin Pharmacol 63 913-916
- [7] Batool S(2011)NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses Nature 475 91-95
- [8] Sadir L(2002)Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression Adv Ther 19 43-52
- [9] Liaquat S(2017)Dopamine system dysregulation in major depressive disorders Int J Neuropsychopharmacol 20 1036-1046
- [10] Shahzad S(2013)Serotonin and beyond: therapeutics for major depression Philos Trans R Soc Lond B Biol Sci 368 20120536-389